In EC, multiple S100 proteins, including S100A1, S100A2, S100A4, S100A8, and S100A9, have been implicated in tumor proliferation, invasion, epithelial–mesenchymal transition (EMT), and response to chemotherapy [11,21,22,23]. The gene discussed is S100A2; the disease is neoplasm.